HK1039946A1 - 來源於sart-1的hla-a2限制性腫瘤抗原肽 - Google Patents

來源於sart-1的hla-a2限制性腫瘤抗原肽

Info

Publication number
HK1039946A1
HK1039946A1 HK02101204.8A HK02101204A HK1039946A1 HK 1039946 A1 HK1039946 A1 HK 1039946A1 HK 02101204 A HK02101204 A HK 02101204A HK 1039946 A1 HK1039946 A1 HK 1039946A1
Authority
HK
Hong Kong
Prior art keywords
tumor antigen
antigen peptide
sart
hla
restraint
Prior art date
Application number
HK02101204.8A
Other languages
English (en)
Inventor
伊東恭悟
小林照忠
Original Assignee
伊東恭悟
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 伊東恭悟 filed Critical 伊東恭悟
Publication of HK1039946A1 publication Critical patent/HK1039946A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK02101204.8A 1998-07-28 2002-02-19 來源於sart-1的hla-a2限制性腫瘤抗原肽 HK1039946A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21294098 1998-07-28
PCT/JP1999/004010 WO2000006595A1 (fr) 1998-07-28 1999-07-27 Peptide d'antigene de tumeur limitant hla-a2 provenant de sart-1

Publications (1)

Publication Number Publication Date
HK1039946A1 true HK1039946A1 (zh) 2002-05-17

Family

ID=16630822

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02101204.8A HK1039946A1 (zh) 1998-07-28 2002-02-19 來源於sart-1的hla-a2限制性腫瘤抗原肽

Country Status (12)

Country Link
US (1) US6664232B1 (zh)
EP (1) EP1103561B1 (zh)
KR (1) KR20010071033A (zh)
CN (1) CN1262562C (zh)
AT (1) ATE323719T1 (zh)
AU (1) AU765733B2 (zh)
CA (1) CA2336486A1 (zh)
DE (1) DE69930942D1 (zh)
HK (1) HK1039946A1 (zh)
ID (1) ID27162A (zh)
NZ (1) NZ509585A (zh)
WO (1) WO2000006595A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080254445A1 (en) * 2003-09-22 2008-10-16 Kyogo Itoh Prognosis in Cancer Patients Vaccinated with a Cancer Antigen Peptide-Associated Agent
ES2390967T3 (es) * 2004-01-20 2012-11-20 Aichi Prefecture Epítopo/péptido reconocido por LTC específico para Ep-CAM con restricción por ALH-A2402 y su utilización
TWI455721B (zh) * 2007-12-05 2014-10-11 Int Inst Cancer Immunology Inc 癌疫苗組合物
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
RU2532105C2 (ru) 2008-10-22 2014-10-27 Онкотерапи Сайенс, Инк. Эпитопные пептиды rab6kifl/kif20a и содержащие их вакцины

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009715A1 (en) 1990-11-21 1992-06-11 Leningradskaya Assotsiatsia 'poliplazma' Method for plasma jet spraying of biologically active coatings on an implant
US5554724A (en) * 1994-03-24 1996-09-10 University Of Leiden Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof
EP0911397A4 (en) 1996-06-07 2002-10-09 Kyogo Itoh TUMORANTANT PROTEINS, THEIR GENES, AND TUMORANTANT PEPTIDES
EP1055684A4 (en) 1997-12-05 2002-12-04 Kyogo Itoh TUMORANTIGENS IN THE FORM OF PEPTIDE DERIVATIVES
US6838445B1 (en) 1998-07-10 2005-01-04 Kyogo Itoh Tumor antigen peptide originating in SART-1

Also Published As

Publication number Publication date
CN1310723A (zh) 2001-08-29
NZ509585A (en) 2003-05-30
WO2000006595A1 (fr) 2000-02-10
KR20010071033A (ko) 2001-07-28
ATE323719T1 (de) 2006-05-15
AU765733B2 (en) 2003-09-25
EP1103561A4 (en) 2002-03-27
EP1103561A1 (en) 2001-05-30
DE69930942D1 (de) 2006-05-24
ID27162A (id) 2001-03-08
CN1262562C (zh) 2006-07-05
US6664232B1 (en) 2003-12-16
AU4801699A (en) 2000-02-21
EP1103561B1 (en) 2006-04-19
CA2336486A1 (en) 2000-02-10

Similar Documents

Publication Publication Date Title
HK1067645A1 (en) Tumor antigen peptides originating in cyclophilin b
CY1114164T1 (el) Μεθοδος ελεγχου της δραστικοτητας ανοσολογικα λειτουργικου μοριου
CY1109699T1 (el) Νουκλεινικα οξεα που κωδικοποιουν πολυπεπτιδια πολυεπιτοπων
IL153996A0 (en) Polypeptides containing at least a portion of an ovarian carcinoma protein, polynucleotides encoding the same and pharmaceutical compositions containing the same
BR9913446A (pt) Produtos de aglicona e métodos de uso
CY1109710T1 (el) Επιτοπα βοηθητικων τ λεμφοκυτταρων
ATE464383T1 (de) Tumor antigen
EP1103561A4 (en) HLA-A2 LIMITING TUMOR ANTIGEN PEPTIDE FROM SART-1
HK1041290A1 (en) Novel tumor antigen protein sart-3 and tumor antigen peptide thereof
WO1999063945A3 (en) Vaccination strategy to prevent and treat cancers
WO2001029220A3 (en) Mage-a12 antigenic peptides and uses thereof
CY1105820T1 (el) Basb027 πρωτεϊνες και γονιδια απο moraxella catarrhalis, αντιγονα, αντισωματα και χρησεις
PL345793A1 (en) Neisseria meningitidis
AU3931599A (en) Basb019 proteins and genes from (moraxella catarrhalis), antigens, antibodies, and uses
EP2270169A3 (en) Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
CO5280140A1 (es) Antigeno (c42) asociado a tumores
ATE281524T1 (de) Moraxella catarrhalis pilq proteine
WO1992016623A3 (en) Receptors for bombesin-like peptides
DE60019614D1 (de) Moraxella catarrhalis antigen basb117
ATE293692T1 (de) Moraxella catarrhalis antigen basb120
MX9604252A (es) Polipeptidos para diagnosticar infeccion con trypanosoma cruzi.
CY1108790T1 (el) Συνθεσεις για τη θεραπεια και διαγνωση ωοθηκικου καρκινου